The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 341.50
Bid: 0.00
Ask: 427.00
Change: 0.00 (0.00%)
Spread: 86.50 (25.404%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 341.50
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Oct 2020 13:37

RNS Number : 9935A
Ascential PLC
02 October 2020
 

 

2 October 2020

 

Ascential plc ("the Company")

Grant of LTIP awards

On 1 October 2020, the Company's Executive Directors were granted conditional awards over ordinary shares under the Executive Deferred Annual Bonus Plan ("DABP") and the Performance Share Plan ("PSP") as noted below.

 

The Remuneration Committee suspended its plans to award shares to the Executive Directors under the Company's PSP and DABP plans, normally granted in March 2020, in response to the uncertainty presented by Covid-19 and the consequent challenges with establishing appropriate performance conditions for the PSP award. In light of the continuing challenges with forecasting earnings over a three-year period, the Remuneration Committee has concluded that the most appropriate performance criteria for this grant is 100% relative total shareholder return (measured against the constituents of the FTSE 250 Index excluding Investment Trusts) with performance to be measured over the three year period running from the date of grant. This is intended to ensure alignment with shareholders during a period of continued uncertainty. The relative total shareholder return performance condition will also be subject to a financial underpin that will require the Remuneration Committee to consider the vesting outcome to be appropriate in light of the underlying financial performance of the Company over the three-year period. If this is not the case, the Remuneration Committee will retain the ability to reduce vesting.

 

The share price used to calculate the number of shares under award is the average of the closing Ascential share price for the five business days immediately preceding 1 October 2020 which is £2.89. This share price is above the five business day average to 27 March 2020 of £2.32 which would have been the grant date but for the delay in this year's awards. The delay in awarding the shares has therefore resulted in a lower number of shares being granted than would otherwise have been the case.

 

In accordance with the Directors' Remuneration Policy approved at the 2020 AGM, Executive Directors can opt to defer up to 100% of their annual bonus into deferred shares (there is mandatory deferral over 50%). Duncan Painter has elected to defer 100% of the annual bonus payable to him in respect of 2019 performance into shares. 50% of the annual bonus payable to Mandy Gradden has been deferred into shares. Subject to the terms of the DABP, the awards will ordinarily vest on the third anniversary of the grant of the awards subject to the grantee's continued service.

 

 

The following grants have therefore been made:

 

Executive Director

Number of shares awarded under the DABP

Number of shares awarded under the PSP

Duncan Painter

61,409

381,626

Mandy Gradden

20,709

225,229

 

The PSP awards will vest subject to the following performance criteria:

 

Target

Weighting

Threshold (25%)

Stretch (100%)

Measurement period

Relative TSR vs FTSE 250 excluding Investment Trusts

100%

Median

Upper Quartile

Average Return Index of the Company and each member of the constituent group during the three-month period ending on 1 October 2020 compared to the Average Return Index during the three-month period to 1 October 2023.

 

Vesting between threshold and maximum will be measured on a straight line basis. Shares normally vest on the third anniversary of the grant, subject to a further two-year holding period whereby the Executive Directors will be restricted from selling the net-of-tax shares which vest.

 

Contacts

 

Louise Meads, Company Secretary

+44 (0) 207 516 5042

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Names

 

 

Duncan Painter

Mandy Gradden

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Ascential plc

b)

 

LEI

 

 

213800VDXQDA7KD2IQ21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p

 

Identification code

BYM8GJ0

b)

 

Nature of the transaction

 

 

Grant of conditional awards under the Executive Deferred Annual Bonus Plan ("DABP") and the Performance Share Plan ("PSP")

c)

 

Price(s) and volume(s)

Duncan Painter:

Price(s)

Volume(s)

Nil

443,035

 

Mandy Gradden:

Price(s)

Volume(s)

Nil

245,938

d)

 

Aggregated information

- Aggregated volume

Duncan Painter - 443,035

Mandy Gradden - 245,938

 

- Price

Nil

e)

 

Date of the transaction

 

 

1 October 2020

f)

 

Place of the transaction

 

 

London

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAAEAEDSEFFA
Date   Source Headline
1st May 202011:33 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSCovenant amendments and Q1 trading update
21st Apr 20205:02 pmRNSHolding(s) in Company
20th Apr 20204:38 pmRNSUpdate on 2020 AGM
16th Apr 20205:02 pmRNSHolding(s) in Company
3rd Apr 20202:30 pmRNSHolding(s) in Company
3rd Apr 20207:00 amRNSCannes Lions Cancellation & Other Actions
2nd Apr 20201:00 pmRNSEdge by Ascential launches Market Share 2.0
1st Apr 20205:23 pmRNSTotal Voting Rights
24th Mar 20202:00 pmRNSMoney20/20 Europe deferral to September 2020
18th Mar 20201:00 pmRNSCannes Lions deferral to contingency dates
17th Mar 20207:00 amRNSTransaction in Own Shares
16th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20209:37 amRNSHolding(s) in Company
12th Mar 20205:51 pmRNSTransaction in Own Shares
11th Mar 20205:26 pmRNSTransaction in Own Shares
11th Mar 202012:00 pmRNSContingency Dates - Cannes Lions & Money20/20 Eu
10th Mar 20205:39 pmRNSTransaction in Own Shares
9th Mar 20205:21 pmRNSTransaction in Own Shares
6th Mar 20204:57 pmRNSTransaction in Own Shares
5th Mar 20205:04 pmRNSTransaction in Own Shares
4th Mar 20205:32 pmRNSTransaction in Own Shares
3rd Mar 20204:42 pmRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSTransaction in Own Shares
28th Feb 20204:44 pmRNSTransaction in Own Shares
27th Feb 20205:48 pmRNSDirector/PDMR Shareholding
27th Feb 20205:46 pmRNSTransaction in Own Shares
26th Feb 20205:35 pmRNSTransaction in Own Shares
26th Feb 202010:04 amRNSTransaction in Own Shares
26th Feb 202010:01 amRNSShare repurchase programme
24th Feb 202010:56 amRNSCorrection to Dividend Date
24th Feb 20207:00 amRNSFinal Results
4th Feb 20201:00 pmRNSHolding(s) in Company
30th Jan 20207:03 amRNSSale of investment in Jumpshot Inc
9th Jan 202010:00 amRNSNotice of Results
8th Jan 20209:00 amRNSEdge by Ascential and The Coca-Cola Company
2nd Jan 20207:00 amRNSTotal Voting Rights
28th Nov 20192:21 pmRNSHolding(s) in Company
22nd Nov 201910:39 amRNSExternal Directorship
13th Nov 20195:52 pmRNSHolding(s) in Company
25th Oct 20197:00 amRNSMoney20/20 China
1st Oct 20192:50 pmRNSTotal Voting Rights
30th Sep 20193:32 pmRNSDirector/PDMR Shareholding
30th Sep 201910:16 amRNSHolding(s) in Company
28th Aug 20195:28 pmRNSHolding(s) in Company
30th Jul 20194:32 pmRNSHolding(s) in Company
30th Jul 20191:07 pmRNSHolding(s) in Company
22nd Jul 20197:01 amRNSStrategic investment in Jumpshot Inc
22nd Jul 20197:00 amRNSHalf-year Report
14th Jun 20197:01 amRNSCannes Lions Announces 2019 Award Entry Numbers

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.